Trial Profile
Efficacy of Humira in Behcet Patients With Arthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Arthritis
- Focus Therapeutic Use
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism
- 25 Oct 2016 Status changed from recruiting to completed.
- 02 Jun 2015 Planned End Date changed from 1 Sep 2016 to 1 Sep 2017 as reported by ClinicalTrials.gov record.